Drug intelligence / Profile preview

Aliatop Crema Fluida

Development stage
Unknown
Lead developer
Epitech
Modality
Small Molecules
Administration
Topical
01

Overview

Aliatop Crema Fluida is a topical medical device developed by Epitech Group SpA for the symptomatic treatment of inflammatory skin conditions, including atopic dermatitis, irritative contact dermatitis, and allergic contact dermatitis. Its mechanism of action is based on ALIAmides (Autacoid Local Inflammation Antagonism), which are endogenous lipid-like molecules that modulate the activity of mast cells and non-neuronal immune cells to control local inflammatory and allergic responses. The formulation also contains phytosphingosine to manage resident microbial flora and support skin barrier restoration, hyaluronic acid to facilitate epidermal cell turnover, and sodium pyroglutamate for its emollient and moisturizing properties. It is specifically marketed for pediatric use to alleviate itching, burning, and skin rashes associated with erythematous-squamous dermatoses.

Brand names
Aliatop Crema FluidaAliatop
Other names
ALIATOP® CREMA FLUIDA

Beyond the preview

Go deeper on Aliatop Crema Fluida.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aliatop Crema Fluida.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call